Navigation Links
New Compassionate Allowances for Social Security Disability Represent 'Outstanding Achievement,' NORD Says
Date:10/27/2008

WASHINGTON, Oct. 27 /PRNewswire-USNewswire/ -- Peter Saltonstall, president of the National Organization for Rare Disorders (NORD), today called the Social Security Administration's new Compassionate Allowances initiative "an outstanding achievement" that will greatly benefit people with certain rare diseases.

The initiative announced today will fast-track applications for Social Security disability for applicants with any of 25 rare diseases and 25 cancers whose medical conditions are very severe. Currently, many people with rare diseases experience devastating delays when they apply for Social Security assistance because those making the decisions are not familiar with their diseases.

"It has taken Social Security less than a year to develop this much-needed program that will benefit those whose claims merit expedited consideration based on the nature of their disease," Saltonstall said. "Disability backlogs cause a hardship for patients and their families. Social Security Commissioner Michael Astrue and his staff deserve our thanks for a job well done."

At the same time, he added, "This program is just a start. There are 6,000 to 7,000 known rare diseases, many of which could qualify for compassionate allowance. NORD is committed to working with SSA to bring many more rare diseases under this program."

Many people with rare diseases encounter delays of months or even years when they apply for assistance through SSA. Often, people with rare diseases initially are denied assistance but later reapply, often with the help of an attorney, and ultimately are approved. The delay and expense of attorney fees can be overwhelming to people who are already coping with serious illness, major medical expenses, and loss of ability to perform normal activities, including work.

In February 2007, Astrue was named Commissioner of Social Security and, several months afterward, he announced that addressing this problem would be a priority for his administration. Speaking at NORD's annual conference for patients and families in September 2007, he underscored his intention to reduce or eliminate needless delay in the application process for people with serious or life-threatening rare diseases.

In December 2007, SSA hosted hearings in Washington, DC, at which Diane Dorman, NORD's Vice President for Public Policy, spoke on behalf of the rare disease patient community. Medical experts, including clinicians and researchers, also spoke at the hearings.

Since then, many members of the rare disease community have provided information about specific rare diseases to SSA. In addition, SSA has partnered with the NIH Office of Rare Diseases to better understand the more than 6,000 diseases in the U.S. classified as rare. A rare disease is one affecting fewer than 200,000 Americans.

To read more about rare diseases, go to NORD's website (http://www.rarediseases.org). To view the list of 25 rare diseases, and 25 cancers, go to http://www.socialsecurity.gov/compassionateallowances.


'/>"/>
SOURCE National Organization for Rare Disorders (NORD)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program
2. AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards
3. Families Mourning Children Travel to Nashville for July Compassionate Friends National Conference
4. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
5. Cognitive Activities Protect Against Alzheimers -- Social and Physical Activities Not Enough
6. MJGC Welcomes New Director of Social Work Alla Lerner
7. Civil Rights and Medical Leaders Call for Social Justice in Health Care
8. Multicountry review shows that Bug Buster Kits reduce head lice and social stigma
9. Hartford Foundation awards grant to address geriatric social work shortage
10. Study to consider social risk in guiding prevention of heart disease
11. IOM advisory: improving cancer patients psychosocial care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology: